Studies have reported that APN/CD13 is overexpressed in endothelial cells of the tumor vascular network and in some solid tumors (melanoma, prostate carcinoma, lung cancer, pancreatic adenocarcinoma, ovarian cancer, breast cancer, colon cancer, etc.). This evidence concerns the gene ANPEP and breast cancer.